Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Vladimir Rogovskii"'
Autor:
Vladimir Rogovskii
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/9a6a7c86203347b6a7da2c2cdd745f01
Autor:
Vladimir Rogovskii
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/edf871452092440d80b69fa3525fa208
Autor:
Vladimir Rogovskii
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/dacfba7282cb4513ac3dbfb570491fac
Autor:
Mikhail Melnikov, Svetlana Sharanova, Anastasiya Sviridova, Vladimir Rogovskii, Nina Murugina, Anna Nikolaeva, Yulia Dagil, Vladimir Murugin, Tatiana Ospelnikova, Alexey Boyko, Mikhail Pashenkov
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240305 (2020)
Glatiramer acetate (GA) is approved for the treatment of multiple sclerosis (MS). However, the mechanism of action of GA in MS is still unclear. In particular, it is not known whether GA can modulate the pro-inflammatory Th17-type immune response in
Externí odkaz:
https://doaj.org/article/faa5b240c1da436eb10222a7f1b195a2
Autor:
Mikhail Pashenkov, M V Melnikov, Vladimir V. Murugin, Vladimir Rogovskii, Anastasiya Sviridova, Alexey Boyko, Vladimir Kudrin
Publikováno v:
Current Neuropharmacology. 20:1632-1639
Background: Dopamine is one of the main mediators capable regulate the neuroimmune interaction and is involved in multiple sclerosis (MS) pathogenesis. Methods: 34 relapsing-remitting MS patients and 23 healthy subjects were examined. To assess the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4697e858cb9a80c0e74d43fd9c5e8b24
https://doi.org/10.2174/1570159x19666210823103859
https://doi.org/10.2174/1570159x19666210823103859
Autor:
Vladimir Rogovskii
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 22:2385-2392
Background: Disease-modifying therapy in cancer can be defined as long-term treatment that has a beneficial outcome on the course of cancer, affecting the underlying pathophysiology of cancer. The anticancer potential of polyphenols is widely studied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feb906ef0419cd1a73bf260d3133584e
https://doi.org/10.2174/1871520622666220201105204
https://doi.org/10.2174/1871520622666220201105204
Autor:
O. V. Boyko, M. A. Omarova, M V Melnikov, A N Boyko, A. M. Zatevalov, O. G. Zhilenkova, Vladimir Rogovskii, A. R. Kabaeva
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 1S, Pp 27-30 (2021)
According to numerous studies, gut microbiota plays a significant role in multiple sclerosis (MS) development. However, data on changes in the gut microbiota in MS is often contradictory. The most common approach in gut microbiota research is the 16S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b83c0505684e9b952e2587d13cb7ee4
https://nnp.ima-press.net/nnp/article/view/1644
https://nnp.ima-press.net/nnp/article/view/1644
Publikováno v:
Medicine of Extreme Situations.
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system involving autoimmune mechanisms. MS has been treated as a disorder mediated mainly by T cells for a long time. However, recent findings demonstrate that B lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de8d018321097387755f31bc5cdec165
https://doi.org/10.47183/mes.2021.020
https://doi.org/10.47183/mes.2021.020
Autor:
Mikhail, Melnikov, Anastasiya, Sviridova, Vladimir, Rogovskii, Vladimir, Kudrin, Vladimir, Murugin, Alexey, Boyko, Mikhail, Pashenkov
Publikováno v:
Current neuropharmacology. 20(8)
Dopamine is one of the main mediators capable regulate the neuroimmune interaction and is involved in multiple sclerosis (MS) pathogenesis.The aim of this study was to clarify the role of dopamine and its receptors in modulation of Th17-cells in MS.3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1c4427b6e94343921b69eace0c321c9
https://pubmed.ncbi.nlm.nih.gov/34429055
https://pubmed.ncbi.nlm.nih.gov/34429055
Publikováno v:
Journal of Neuroimmune Pharmacology. 15:37-47
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) with an autoimmune mechanism of development. Currently, one of the most promising directions in the study of MS pathogenesis are the neuroimmu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885faa9e8fc18615e958d8146e3762a0
https://doi.org/10.1007/s11481-019-09852-3
https://doi.org/10.1007/s11481-019-09852-3